Ginolis
Private Company
Total funding raised: $11.7M
Overview
Ginolis is a Finland-based provider of automation and robotics solutions for diagnostic and medical device production, bridging the gap between laboratory research and full-scale commercial manufacturing. The company's core offerings include the Kaste family of precision liquid dispensing platforms and the LFDA series of modular lateral flow device assembly lines, which are used by hundreds of customers globally to produce over 100 million diagnostic devices annually. Operating as a private company, Ginolis generates revenue by selling and servicing its automation equipment and customized systems, catering to a diverse clientele from startups to global leaders in the life sciences industry. Its technology is deployed in 37 countries, supporting applications in drug discovery, assay development, biosensor manufacturing, and point-of-care diagnostics.
Technology Platform
The Kaste precision liquid dispensing platform (1 nL to 1500 µL, <3% CV) and the modular LFDA series of robotic lateral flow device assembly lines. Together, they provide an ecosystem for automating diagnostic manufacturing from reagent deposition to final device assembly.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Ginolis competes in the niche of diagnostic production automation against larger laboratory automation companies (e.g., Tecan, PerkinElmer) and specialized firms focusing on lateral flow or dispensing technology. Its differentiation lies in its specific focus on the end-to-end transition from R&D to production and its modular, customizable approach for diagnostic device assembly.